Glycolysis-related five-gene signature correlates with prognosis and immune infiltration in gastric cancer

doi:10.4251/wjgo.v16.i7.3097

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1407)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-2) series.

Item

Count

PDF

HTML

912

Figures (1-8)

123

Tables (1-2)

Sum=1165

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

144

Sum=188

Jul 15, 2024 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3097-3117
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3097

Table 1 Cox proportional risk model of the five genes from the differentially expressed gene analysis based on The Cancer Genome Atlas

Gene	HR	P value	Lower	Upper
SDC2	1.198408375	0.002623116	1.065124145	1.348371118
VCAN	1.254174878	0.005099287	1.070349846	1.469570562
ME1	1.207011799	0.019435313	1.030825077	1.413312031
PC	1.199767177	0.030505733	1.017278658	1.414992115
SOX9	0.811543291	0.04660378	0.660673598	0.996865191

HR: Hazard ratio; SDC2: Signature comprising syndecan 2; VCAN: Versican; ME1: Malic enzyme 1; PC: Pyruvate carboxylase; SOX9: SRY-box transcription factor 9.

Citation: Meng XY, Yang D, Zhang B, Zhang T, Zheng ZC, Zhao Y. Glycolysis-related five-gene signature correlates with prognosis and immune infiltration in gastric cancer. World J Gastrointest Oncol 2024; 16(7): 3097-3117
URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3097.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3097